FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and represents mutant tobacco peroxidase characterised by amino acid sequence corresponding to that of tobacco peroxidase Nicotiana tabacum wherein the remaining threonine in position 151 is substituted by the remaining tryptophane.
EFFECT: invention allows preparing new protein with peroxidase properties and thereby improved catalytic properties as related to substrata series.
3 dwg
Authors
Dates
2009-07-10—Published
2007-11-27—Filed